Related Experiment Video
Updated: Jan 8, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Unravelling Mechanisms of Cancer Cells' Tropism for Metastasis: A Key to Improved Cancer Therapies
Sumit Mallick1, Jahnvi Hora2,3, T K Varun1
1Stem Cells and Regenerative Medicine Centre, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Abstract:
Selective migration of tumors to particular organs, referred to as organ tropism, is not arbitrary but guided by intricate molecular interactions and a complex network of various secretory molecules. This site-specific migration is modulated by molecular crosstalk, where cytokines and other effectors help tumor cells adapt to and colonize a new organ by reshaping their epigenetics. It is well established that breast and colorectal cancers, for instance, can epigenetically modify themselves to show a preference for the brain, bones, lungs, and liver but the key modulators are still elusive. Here, we have discussed the key mechanisms, including the critical interacting molecules, cytokines, and pathways that drive this site-specific tropism-based colonization. By synthesizing current knowledge, we highlight central players in this process and discuss their potential as therapeutic targets to inhibit metastasis and improve patient outcomes.
Insights
Tumor cells selectively migrate to specific organs through organ tropism, driven by molecular interactions and epigenetic changes. Identifying key modulators could lead to new therapies to inhibit cancer metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Tumor cell metastasis exhibits organ tropism, a non-random process.
- Molecular interactions and secretory molecules guide tumor cell migration to specific organs.
- Cytokines and epigenetic modifications enable tumor cells to colonize distant sites.
Purpose of the Study:
- To elucidate the key mechanisms driving site-specific tumor colonization.
- To identify critical interacting molecules, cytokines, and pathways involved in organ tropism.
- To highlight potential therapeutic targets for inhibiting metastasis.
Main Methods:
- Literature synthesis of current knowledge on tumor metastasis and organ tropism.
- Analysis of molecular crosstalk and epigenetic reprogramming in cancer cells.
- Identification of key players and pathways mediating site-specific colonization.
Main Results:
- Organ tropism is mediated by complex molecular crosstalk and epigenetic changes.
- Specific cytokines and interacting molecules play critical roles in guiding tumor cell migration.
- Key modulators of breast and colorectal cancer tropism to brain, bones, lungs, and liver remain to be fully elucidated.
Conclusions:
- Understanding the molecular basis of organ tropism is crucial for developing targeted therapies.
- Key players identified offer potential therapeutic targets to inhibit cancer spread.
- Further research into these modulators could significantly improve patient outcomes in metastatic cancer.
More Related Videos
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chemotaxis and Direction of Cell Migration
Tumor Immunotherapy